Remove Cancer Remove Cardiothoracic Remove CME
article thumbnail

8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC

Society of Thoracic Surgeons - Surgeon

Dwight Owen (Ohio State University) discussed advances in biomarker testing and neoadjuvant immunotherapy for resectable non-small cell lung cancer. The Society’s 8 in 8 Series offers quick access to important topics in cardiothoracic surgery. No CME credit is associated with the viewing of web-based content. Duration 7 min.